Antifolates agents work by antagonizing (blocking) the actions of folic acid (vitamin B9).Antifolates have a cytotoxic effect on cells during the S-phase of the cell cycle, acting specifically during DNA and RNA synthesis. Antifolates that target folate metabolism have been crucial in the development of medications for the treatment of inflammatory, microbial, parasitic, and cancerous diseases.
Antifolates prevent cell division, DNA/RNA synthesis and repair, and protein synthesis because folate (folic acid) cofactors are necessary for the synthesis and metabolism of amino acids. Some drugs, including proguanil, pyrimethamine, and trimethoprim, specifically block the effects of folate on bacteria, protozoa, and fungi. Dihydrofolate reductase (DHFR), thymidylate synthase (TS), GARFTase, and AICARFTase are examples of prominent antifolate enzyme targets and the antifolates that specifically target these enzymes.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V109034 | AGF347 | 2294820-23-6 | AGF347 is a potent multi-target antifolate drug that targets serine hydroxymethyltransferase (SHMT)2 in mitochondria and SHMT1 in the cytoplasm, thereby inhibiting de novo purine synthesis. |
|
V120150 | Antifolate agent 1 | 518063-75-7 | Antifolate agent 1 (compound 1) is a folic acid antifolate with a single carbon bridge. |
|
V80022 | Antitumor agent-99 | Antitumor agent-99 (compound 7) is an anticancer agent targeting FRα/β and PCFT. | |
|
V77116 | Cycloguanil-d6 (Chlorguanide triazine-d6) | Cycloguanil-d66 is the deuterated compound standard of Cycloguanil. | |
|
V52100 | Fanotaprim (VYR-006) | 2120282-75-7 | Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor (antagonist) with IC50s of 1.57 and 308 nM for tgDHFR (Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively. |
|
V136365 | FR-β ligand 1 | 863869-78-7 | FR-β ligand 1 is a folate receptor-targeting ligand with antitumor activity, high selectivity, and stronger affinity for the folate receptor. |
|
V136364 | FRα-targeting peptide C7 TFA | FRα-targeting peptide C7 TFA is a selective folate receptor α (FRα) ligand that can specifically bind to cells expressing FRα and has in vivo tumor targeting capabilities. | |
|
V80562 | Levomefolate-13C5 calcium (5-Methyltetrahydrofolic Acid-13C5 (calcium salt)) | Levomefolate-13C5 (calcium) is a 13C (carbon 13)-labeled Levomefolate (calcium). | |
|
V56538 | Methotrexate metabolite-d3 (DAMPA-d3) | 1794780-00-9 | Methotrexate metabolite-d3 is the deuterium labelled form of Methotrexate metabolite. |
|
V115173 | MX-68 | 156579-02-1 | MX-68 is an orally effective antifolate drug. |
|
V106403 | Opugotamig | Opugotamig is a half-IG G1-κ/(scFv-κ-heavy)-h-CH2-CH3 chimeric antibody against FOLR1. | |
|
V52603 | Proguanil-d4 (proguanil-d4) | 1189805-15-9 | Proguanil-d4 is the deuterium labelled form of Proguanil. |
|
V56376 | Proguanil-d4 hydrochloride | 1189671-34-8 | Proguanil-d4 ( HCl) is the deuterium labelled form of Proguanil HCl. |
|
V52542 | Pyrimethamine-d3 (Pyrimethamine-d3) | 1189936-99-9 | Pyrimethamine-d3 is the deuterium labelled form of Pyrimethamine. |
|
V106406 | Rinatabart | Rinatabart is an IgG1κ human antibody directed against FOLR1. | |
|
V35227 | Talotrexin (PT523) | 113857-87-7 | Talotrexin (PT523) is an analog of Aminopterin , a non-polyglutamic acid classical antifolate. |
|
V35207 | Tetroxoprim (HE 781) | 53808-87-0 | Tetroxoprim is an inhibitor (blocker/antagonist) of the antibacterial DHFR. |
|
V35013 | Trimethoprim lactate (Trimethoprim lactate) | 23256-42-0 | Trimethoprim lactate is an antibacterial antibiotic and an orally bioactive dihydrofolate reductase inhibitor. |
|
V56323 | Trimethoprim-d3 (trimethoprim d3) | 1189923-38-3 | Trimethoprim-d3 is the deuterated form of Trimethoprim. |
|
V52820 | Trimethoprim-d9 (Trimethoprim d9) | 1189460-62-5 | Trimethoprim-d9 is the deuterium labelled form of Trimethoprim. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
